MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALGS — Aligos Therapeutics, Inc. Common Stock
NasdaqAligos Therapeutics, Inc. Common Stock
$5.50
-0.13(-2.31%)
- O
- 5.69
- H
- 5.74
- L
- 5.37
- V
- 28.26K
⏱️ End-of-day dataAs of Oct 1, 2026
ALGS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash Equivalents | $29.98M | $18.30M | N/A | N/A | $73.76M | $37.00M |
| Cash And Cash Equivalents | $29.98M | $18.30M | $41.95M | $18.66M | $73.76M | $37.00M |
| Other Short Term Investments | $24.93M | $59.54M | $57.15M | $10.43M | $64.10M | $19.94M |
| Restricted Cash | 174,000.00 | 110,000.00 | 110,000.00 | 110,000.00 | 110,000.00 | 110,000.00 |
| Other Current Assets | $4.55M | $4.91M | $4.23M | $4.89M | $5.23M | $5.09M |
| Total Current Assets | $59.63M | $82.86M | $10.34M | $12.79M | $14.32M | $62.14M |
| Properties | $8.84M | $9.30M | $9.71M | $10.17M | $10.64M | $10.94M |
| Machinery Furniture Equipment | $2.13M | $2.11M | $2.09M | $2.08M | $2.09M | $2.06M |
| Leases | $6.26M | $6.26M | $6.10M | $6.10M | $6.10M | $6.10M |
| Accumulated Depreciation | $-13.06M | $-12.71M | $-12.46M | $-12.23M | $-11.98M | $-11.78M |
| Other Non Current Assets | 759,000.00 | 715,000.00 | 713,000.00 | 640,000.00 | 632,000.00 | 627,000.00 |
| Total Non Current Assets | $4.93M | $5.67M | $6.33M | $6.76M | $7.49M | $7.95M |
| Total Assets | $64.56M | $88.53M | $10.98M | $13.47M | $15.07M | $70.09M |
| Accounts Payable | $7.64M | $3.98M | $4.65M | $3.94M | $4.46M | $2.57M |
| Accrued Expenses | $7.77M | $6.06M | $8.32M | $6.58M | $6.40M | $7.70M |
| Short Term Debt | $3.69M | $3.73M | $3.56M | $3.54M | $3.49M | $3.46M |
| Pensions | $4.22M | $7.46M | $5.28M | $4.42M | $3.45M | $6.39M |
| Total Current Liabilities | $23.32M | $21.23M | $21.99M | $20.27M | $18.95M | $21.74M |
| Long Term Debt | 659,000.00 | $1.52M | $2.50M | $3.34M | $4.39M | $4.92M |
| Derivative Product Liabilities | $8.79M | $12.18M | $13.40M | $9.19M | $10.87M | $72.37M |
| Total Non Current Liabilities | $9.45M | $13.76M | $15.94M | $12.57M | $15.31M | $77.33M |
| Total Liabilities | $32.77M | $34.99M | $37.93M | $32.84M | $34.25M | $99.07M |
| Common Stock | 9,000.00 | 9,000.00 | 9,000.00 | 9,000.00 | 9,000.00 | 8,000.00 |
| Retained Earnings | $-66.52M | $-64.22M | $-62.23M | $-59.08M | $-57.49M | $-61.80M |
| Other Shareholders Equity | 438,000.00 | 468,000.00 | 455,000.00 | 420,000.00 | 447,000.00 | 451,000.00 |
| Total Shareholders Equity | $31.79M | $53.55M | $71.83M | $10.19M | $11.64M | $-28.97M |
| Additional Paid In Capital | $69.66M | $69.53M | $69.37M | $69.22M | $69.09M | $58.86M |
| Construction In Progress | N/A | 0.00 | 163,000.00 | 4,000.00 | 4,000.00 | 4,000.00 |
| Deferred Revenue | N/A | 0.00 | 168,000.00 | 579,000.00 | 0.00 | 151,000.00 |
| Other Non Current Liabilities | N/A | 47,000.00 | 46,000.00 | 46,000.00 | 46,000.00 | 46,000.00 |